Banks deliberate pros and cons of $30bn ChemChina loan
GlobalCapital, is part of the Delinian Group, DELINIAN (GLOBALCAPITAL) LIMITED, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 15236213
Copyright © DELINIAN (GLOBALCAPITAL) LIMITED and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Asia

Banks deliberate pros and cons of $30bn ChemChina loan

beijing_China_230px

The Asian syndication of a jumbo loan to back China National Chemical Corp’s (ChemChina) acquisition of Syngenta is seeing interest from many international lenders in Asia. Banks are weighing the benefits of the borrower’s state ownership against the weakness of its financials on a standalone basis, writes Shruti Chaturvedi.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article